$113.58
0.890.79%
In chiusura: -
$113.52
-0.06-0.05%
After hour: 7:47 PM EDT
Gilead Sciences segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Gilead Sciences utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
GILD | Gilead Sciences | $2.02 | $2.15 | — | — | $7.54B | $7.42B | — | — | 11/05/2025 | |
GILD | Gilead Sciences | $2.01 | $1.95 | $2.01 | 3.08% | $6.95B | $6.96B | $7.08B | 1.77% | 08/07/2025 | |
GILD | Gilead Sciences | -$1.32 | $1.76 | $1.81 | 2.84% | $6.69B | $6.77B | $6.67B | -1.52% | 04/24/2025 | |
GILD | Gilead Sciences | $1.72 | $1.70 | $1.90 | 11.76% | $7.12B | $7.15B | $7.57B | 5.86% | 02/11/2025 | |
GILD | Gilead Sciences | $2.29 | $1.55 | $2.02 | 30.32% | $7.05B | $7.00B | $7.54B | 7.79% | 11/06/2024 | |
GILD | Gilead Sciences | $1.34 | $1.60 | $2.01 | 25.62% | $6.60B | $6.72B | $6.95B | 3.48% | 08/08/2024 | |
GILD | Gilead Sciences | $1.37 | -$1.49 | -$1.32 | 11.41% | $6.35B | $6.34B | $6.69B | 5.46% | 04/25/2024 | |
GILD | Gilead Sciences | $1.67 | $1.78 | $1.72 | -3.37% | $7.39B | $7.09B | $7.12B | 0.35% | 02/06/2024 | |
GILD | Gilead Sciences | $1.90 | $1.92 | $2.29 | 19.27% | $7.04B | $6.80B | $7.05B | 3.69% | 11/07/2023 | |
GILD | Gilead Sciences | $1.58 | $1.61 | $1.34 | -16.77% | $6.26B | $6.43B | $6.60B | 2.63% | 08/03/2023 | |
GILD | Gilead Sciences | $2.12 | $1.54 | $1.37 | -11.04% | $6.59B | $6.33B | $6.35B | 0.35% | 04/27/2023 | |
GILD | Gilead Sciences | $0.69 | $1.49 | $1.67 | 12.08% | $7.24B | $6.64B | $7.39B | 11.28% | 02/02/2023 | |
GILD | Gilead Sciences | $2.65 | $1.48 | $1.90 | 28.38% | $7.42B | $6.12B | $7.04B | 15.07% | 10/27/2022 | |
GILD | Gilead Sciences | $1.87 | $1.53 | $1.58 | 3.27% | $6.22B | $5.86B | $6.26B | 6.83% | 08/02/2022 | |
GILD | Gilead Sciences | $2.08 | $1.80 | $2.12 | 17.78% | $6.42B | $6.28B | $6.59B | 4.94% | 04/28/2022 | |
GILD | Gilead Sciences | $2.19 | $1.58 | $0.69 | -56.33% | $7.42B | $6.64B | $7.24B | 9.10% | 02/01/2022 | |
GILD | Gilead Sciences | $2.11 | $1.74 | $2.65 | 52.30% | $6.58B | $6.25B | $7.42B | 18.74% | 10/28/2021 | |
GILD | Gilead Sciences | $1.11 | $1.73 | $1.87 | 8.09% | $5.14B | $6.07B | $6.22B | 2.42% | 07/29/2021 | |
GILD | Gilead Sciences | $1.68 | $2.09 | $2.08 | -0.48% | $5.55B | $6.74B | $6.42B | -4.70% | 04/29/2021 | |
GILD | Gilead Sciences | $1.30 | $2.15 | $2.19 | 1.86% | $5.88B | $7.33B | $7.42B | 1.24% | 02/04/2021 | |
GILD | Gilead Sciences | $1.75 | $1.95 | $2.11 | 8.21% | $5.60B | $6.39B | $6.58B | 2.93% | 10/28/2020 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-07 | $2.01 | $1.95 | 3.08 % |
Q1 | 2025-04-24 | $1.81 | $1.76 | 2.84 % |
Q4 | 2025-02-11 | $1.90 | $1.70 | 11.8 % |
Q3 | 2024-11-06 | $2.02 | $1.55 | 30.3 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-07 | $7.08B | $6.96B | 1.77 % |
Q1 | 2025-04-24 | $6.67B | $6.77B | -1.52 % |
Q4 | 2025-02-11 | $7.57B | $7.15B | 5.86 % |
Q3 | 2024-11-06 | $7.55B | $7.00B | 7.79 % |
Si prevede che Gilead Sciences (GILD) fornisca risultati il novembre 5, 2025. Gli ultimi risultati sono stati pubblicati il agosto 7, 2025 per il Q2.
L'EPS effettivo era $2.01, che superato la stima di $1.95.
Le entrate effettive sono state $7.1B, che superato la stima di $7B.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.